NAD+ (nicotinamide adenine dinucleotide) sits at the center of cellular energy production. Every living cell depends on it to convert nutrients into ATP, and without enough of it, mitochondria can't do their job (Rajman et al., 2018).

The problem is that NAD+ levels drop steadily with age. By the time you hit your 40s or 50s, you may have half the NAD+ you had in your 20s, and that decline drives many of the symptoms we associate with getting older.

Why NAD+ Matters for Aging

NAD+ does more than power your mitochondria. It also activates sirtuins, a family of seven proteins that regulate DNA repair, inflammation, and stress resistance (Imai & Guarente, 2014).

Sirtuins can't function without NAD+. When NAD+ runs low, sirtuin activity drops, and the cellular repair processes they control slow down or stall entirely.

NAD+ also serves as a signaling molecule that influences circadian rhythms, inflammatory responses, and metabolic flexibility. These aren't minor background functions; they're central to how well your cells perform under stress.

What Causes NAD+ to Decline

Several factors work together to drain NAD+ as you age. Understanding them helps explain why simple supplementation alone often isn't enough.

Chronic inflammation and oxidative stress accelerate all of these processes. Lifestyle factors like poor diet, sedentary behavior, and chronic stress compound the damage further.

Three NAD+-Boosting Peptides

Traditional NAD+ precursors like NMN and NR supply raw materials. Peptides work differently: they target the enzymes and pathways that control how your body makes, uses, and preserves NAD+.

Three peptides stand out for their distinct mechanisms of action.

Head-to-Head Comparison

Each of these peptides targets a different bottleneck in NAD+ metabolism. The table below shows how they compare across key dimensions.

How NAD+ Peptides Work Together

These three peptides aren't redundant. They target different steps in the NAD+ production and preservation chain, which means combining them can address the problem from multiple angles.

5-Amino-1MQ protects NAD+ precursors from being destroyed before they're used. MOTS-c activates AMPK to boost the cell's demand-driven production of NAD+. SS-31 shields the mitochondria where NAD+ is consumed, reducing wasteful oxidative losses.

Used together, they address the supply side, the demand side, and the protection side of NAD+ metabolism.

NAD+ Restoration Protocol

The following protocol combines peptides with NAD+ precursors and lifestyle interventions. It's a framework to discuss with your healthcare provider, not a prescription.

Supplement Timing

Lifestyle Factors That Support NAD+

Peptides work best when paired with behaviors that naturally support NAD+ production. These aren't optional extras; they're foundational.

Monitoring Your NAD+ Status

You can't manage what you don't measure. Tracking biomarkers helps you personalize dosing and confirm that your protocol is actually working.

Work with a functional medicine practitioner who specializes in these advanced biomarkers. Many standard labs don't offer NAD+ or mitochondrial DNA testing.

Who Might Benefit

NAD+ peptides aren't for everyone. They're most relevant for people experiencing specific signs of age-related mitochondrial decline.

Benefits vs. Considerations

Side Effects and Safety

NAD+ peptides are generally well-tolerated in research settings, but they aren't without risk. Here's what the data shows.

Most side effects resolve within hours of reducing dosage. Long-term safety data beyond 12 months is limited for all three peptides, which is something to weigh in your risk-benefit calculation.

Cycling Protocol

Cycling prevents receptor desensitization and maintains your body's natural NAD+ production capacity.

Complementary Longevity Approaches

NAD+ peptides work best as part of a broader longevity strategy. Several other interventions target overlapping but distinct aging pathways.

These combinations should be guided by a knowledgeable healthcare provider who can design a personalized protocol based on your health status and goals.

Frequently Asked Questions

The Bottom Line

The science of NAD+ restoration is still evolving, but the foundational research is strong. Mitochondrial decline drives much of what we experience as aging, and these peptides offer targeted tools to address it.

Start with bloodwork. Build your protocol around data, not guesswork. And remember that peptides are one piece of a larger puzzle that includes exercise, nutrition, sleep, and stress management.

References

Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metab. 2018;27(3):529–547. PubMed
Imai SI, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464–471. PubMed
Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443–454. PubMed
Neelakantan H, et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochem Pharmacol. 2021;147:141–152. PubMed
Birk AV, et al. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol. 2014;24(8):1250–1261. PubMed
Yoshino J, Baur JA, Imai SI. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metab. 2018;27(3):513–528. PubMed
Camacho-Pereira J, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metab. 2016;23(6):1127–1139. PubMed

Related reading:

SS-31 Elamipretide Guide  ·  MOTS-c Mitochondrial Peptide  ·  Peptide Bloodwork Guide  ·  Longevity Stack Guide

For compound profiles and sourcing info, visit PeptideArc.